Princeton’s plan to make a meningitis vaccine — called Bexsero — available to students in the near future likely has few legal ramifications for the University, despite the fact that the U.S. Food and Drug Administration has not yet approved the drug for use in the United States. Since March, eight cases of meningococcal disease linked to the University have been reported. Following the seventh case, the University decided in coordination with the Centers for Disease Control and Prevention and the FDA to import the Bexsero vaccine and offer it to students and certain community members.
Help employers find you! Check out all the jobs and post your resume.
